BeStock  
Stocks › Biotechnology › SANA

Sana Biotechnology SANA

US equityMarket cap rank #3609Biotechnology
$1.59 −$0.15 (-8.62%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $1.64 +3.06%
Open$1.70
Prev close$1.74
Day range$1.57 – $1.75
Volume4.46M
Market cap$476.42M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership79.2%-1.76 pts vs. prior quarter
Institutions holding240-2 vs. prior quarter
Insider trades (recent)37 buys / 10 sellsNet buying
Short interest13.56% of floatDays to cover 15.8 · as of 30 Oct 2026
Short-sale volume share22.8%5-day average of daily volume

Short-sale volume as % of daily volume

15%23%31%39%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$2.12M (7 inflow days, 13 outflow days).

Net flow by order size, last 20 sessions

−$781.4KSuper−$1.3MBig−$1.7MMid−$958.1KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 46.3% of shares outstanding.

Largest holders

  • Arch Venture Partners, L.P.15.31%
  • FMR10.93%
  • Flagship Pioneering, Inc8.34%
  • RA Capital Management, L.P.6.26%
  • BlackRock5.47%
  • Canada Pension Plan Investment Board3.41%
  • State Street Global Advisors3.20%
  • Steven Harr2.99%

By investor type

  • VC/PE Fund32.64%
  • Mutual Fund31.60%
  • Public Company6.38%
  • Individual/Insider6.29%
  • Hedge Fund4.19%
  • Government Pension Fund3.60%
  • Private Company0.57%
  • Insurance Company0.12%

Reported short interest has fallen from 14.22% to 13.56% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Morgan Stanley Public Company 2026/Q3 +1,882,589 1.0%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +1,882,589 1.0%
Franklin Resources Mutual Fund 2026/Q3 +249,084 0.1%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +235,751 2.9%
Squarepoint OPS LLC Hedge Fund 2026/Q3 +211,482 0.1%
Renaissance Technologies Corp. Hedge Fund 2026/Q3 +190,400 0.5%
Putnam LLC Mutual Fund 2026/Q3 +133,350 0.0%
Putnam Fiduciary Trust Company Private Company 2026/Q3 +123,636 0.0%
Putnam LLC Mutual Fund 2026/Q3 +130,655 0.0%
Putnam Fiduciary Trust Company Private Company 2026/Q3 +124,492 0.0%
Dhavalkumar Patel Individual/Insider 2026/Q3 +83,842 0.1%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +347,599 0.1%
Riverbridge Partners, LLC Mutual Fund 2026/Q3 +152,878 0.1%
RA Capital Management, L.P. VC/PE Fund 2026/Q3 +18,750,000 6.3%
Bank of America Corporation Public Company 2026/Q3 +2,794,012 1.9%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
4 Oct 2026 Hans Edgar Bishop Independent Chairperson Other Acquisition +8,680 – 5,863,480
26 Aug 2026 Dhavalkumar Patel Chief Scientific Officer Derivative Exercise and Sale -41,158 $4.11 183,352
25 Aug 2026 Dhavalkumar Patel Chief Scientific Officer Derivative Exercise and Retained +83,842 – 183,352
5 Jul 2026 Hans Edgar Bishop Independent Chairperson Other Acquisition +6,297 – 5,854,800
3 Jun 2026 Robert Taylor Nelsen Independent Director Other Derivative Acquisition +90,000 $2.96 90,000
3 Jun 2026 Yuhmin Yang Independent Director Other Derivative Acquisition +90,000 $2.96 90,000
3 Jun 2026 Michelle Seitz Independent Director Other Derivative Acquisition +90,000 $2.96 90,000
3 Jun 2026 Richard Mulligan Vice Chairperson Other Derivative Acquisition +90,000 $2.96 90,000
3 Jun 2026 Hans Edgar Bishop Independent Chairperson Other Derivative Acquisition +90,000 $2.96 90,000
3 Jun 2026 Joshua Bilenker Independent Director Other Derivative Acquisition +90,000 $2.96 90,000
3 Jun 2026 Alise Reicin Independent Director Other Derivative Acquisition +90,000 $2.96 90,000
3 Jun 2026 Robert Rosiello Independent Director Other Derivative Acquisition +90,000 $2.96 90,000
5 Apr 2026 Hans Edgar Bishop Independent Chairperson Other Acquisition +7,763 – 5,848,503
23 Mar 2026 Dhavalkumar Patel Chief Scientific Officer Initial Statement of Beneficial +0 – 1,396,250
8 Mar 2026 Steven Harr Chief Executive Officer Derivative Exercise and Sale -24,345 $3.13 8,960,751
8 Mar 2026 Susan Wyrick Treasurer, Principal Accounting Officer and Senior VP of Finance & Accounting Derivative Exercise and Sale -4,387 $3.13 196,196
6 Mar 2026 Steven Harr Chief Executive Officer Derivative Exercise and Retained +67,321 – 8,960,751
5 Mar 2026 Susan Wyrick Treasurer, Principal Accounting Officer and Senior VP of Finance & Accounting Derivative Exercise and Retained +9,279 – 196,196
4 Mar 2026 Steven Harr Chief Executive Officer Other Derivative Acquisition +200,000 – 200,000
4 Mar 2026 Steven Harr Chief Executive Officer Other Derivative Acquisition +900,000 $3.41 900,000

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 40,600,271 13.6% 15.8
15 Oct 2026 40,846,893 13.6% 11.0
30 Sep 2026 38,725,699 12.9% 9.0
15 Sep 2026 41,374,811 13.8% 12.2
31 Aug 2026 41,563,334 13.9% 16.1
14 Aug 2026 42,568,975 14.2% 18.0

Discussion

No comments yet — be the first to weigh in on SANA.

Sign in to join the discussion.

Scroll to Top